SARM1 and amyotrophic lateral sclerosis: There is phenotypic heterogeneity in the clinical presentation, reminiscent of other ALS disease genes, and this raises intriguing questions both about the potential pathogenic role of constitutively hyperactive SARM1 and about why their extraordinarily high NADase activity is not immediately lethal.